Table 1.
Studies of the Effect of Antibiotics on Cough Symptoms or Other Outcomes in Patients With Acute Bronchitis*
Drug | Study/Year | Patients, No. | Age,† yr | Population | Dosing | Results | p Value |
---|---|---|---|---|---|---|---|
Erythromycin vs placebo | Hueston60/1994 | 46 | 18–65 | Acute bronchitis | 250 mg po qid × 10 d | Reduction in frequency of cough | NS |
Reduction in mucus production | NS | ||||||
Increased side effects | NS | ||||||
Brickfield et al59/1986 | 52 | 18–65 | Acute bronchitis | 333 mg tid × 7 d | Cough symptoms significantly better on days 3, 5, and 6; magnitude of benefit not given | ≤ 0.5 | |
Dunlay et al58/1987 | 63 | 43.5 | Acute bronchitis | 333 mg tid × 10 d | Cough symptoms; data not shown | NS | |
Brickfield et al59/1986 | 52 | 18–65 | Acute bronchitis | 333 mg tid × 7 d | Cough symptoms; data shown graphically | < 0.05 | |
Dunlay et al58/1987 | 63 | 43.5 | Acute bronchitis | 333 mg tid × 10 d | Day/night cough symptoms | NS | |
King et al57/1996 | 91 | 37 ± 13.7 | Acute bronchitis | 250 mg qid × 10 d | Cough frequency; data not reported | NS | |
Immediate or delayed antibiotics vs placebo | Dowell et al56/2001 | 191 | 39 | Acute cough | Immediate antibiotics (14 d) vs 1 wk delayed antibiotics | Recovery from cough; data in graph form | NS |
Trimethoprim-sulfamethoxazole vs placebo | Franks and Gleiner55/1984 | 67 | 39 | Acute bronchitis | 160/800 mg bid × 7 d | Presence of nighttime cough 56% treatment, 84% placebo | 0.03 |
Daytime cough frequency | NS | ||||||
Presence of cough 93% treatment, 99% placebo | 0.05 | ||||||
Amoxicillin-clavulanic acid vs placebo | Gottfarb and Brauner54/1994 | 52 | 2.65; 0.58–7 | LRI | 20 mg/kg/d × 7 d | Recovery from cough at 7 d in 71% vs 22% | 0.002 |
Amoxicillin/ambroxol vs amoxicillin | Peralta et al53/1987 | 24 | 59.6 ± 8 | Bronchitis | 500/30 mg tid × 10 d | Cough symptoms similar | NS |
Cough clearance improved by 90% | ≤ 0.001 | ||||||
Doxycycline vs placebo | Scherl et al52/1987 | 39 | 30 | Bronchitis | 100 mg bid × 1 d then | No. of days of cough reduced from 15 to 9.4 | NS |
100 mg qd × 6 d | |||||||
Stott and West50/1976 | 212 | NR (14+ yr) | Bronchitis | 100 mg bid × 1 d, then | Daytime cough score similar | NS | |
100 mg qd × 9 d | |||||||
Nighttime cough score similar | NS | ||||||
Verheij et al51/1994 | 158 | NR (18+ yr) | Bronchitis or URI | 200 mg qd × 1 d, then | Percent with cough | ||
100 mg qd × 9 d | |||||||
Williamson49/1984 | 74 | 33.4 | Bronchitis or URI | 200 mg qd × 1 d, then | Cough duration | 0.5 | |
100 mg qd × 6 d | |||||||
Interrupted sleep | NS | ||||||
Cough severity | NS |
NS = not significant; LRI = lower respiratory tract infection; URI = upper respiratory tract infection; NR = not reported.
Values are given as the mean ± SD or range.